Physician profile
Sara E Pike
NPI 1699705632
$1,864.63
in general payments reported to CMS, 2019-2025
14 companies · $498 in 2025
The $498 reported for 2025 was more than what 77% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135 · 2020: $35.39 · 2021: $153 · 2022: $141 · 2023: $532 · 2024: $371 · 2025: $498.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,399.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lkc Technologies, INC. | $572.67 | 2023-2025 | |
| Bausch & Lomb Americas INC. | $325.46 | 2023-2025 | Infuse, Vyzulta, Miebo |
| Sun Pharmaceutical Industries INC. | $306.03 | 2019-2023 | Cequa |
| Coopervision INC. | $163.77 | 2023-2024 | Misight Contact Lens, Clariti Contact Lens |
| Glaukos Corporation | $137.27 | 2021 | |
| Biotissue Holdings INC. | $81.90 | 2023 | |
| Amgen INC. | $63.32 | 2024 | Tepezza |
| Novartis Pharmaceuticals Corporation | $48.93 | 2020-2022 | |
| Alcon Vision LLC | $45.98 | 2019-2025 | Precision7 |
| Sight Sciences, INC. | $30.38 | 2023 | Tearcare System |
| Allergan, INC. | $24.78 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $23.98 | 2023 | Acuvue |
| Tarsus Pharmaceuticals, INC. | $21.64 | 2025 | Xdemvy |
| Plexus Optix, INC. | $18.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Pike listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.